0001181431-13-043445.txt : 20130807 0001181431-13-043445.hdr.sgml : 20130807 20130807191109 ACCESSION NUMBER: 0001181431-13-043445 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20130806 FILED AS OF DATE: 20130807 DATE AS OF CHANGE: 20130807 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: IPC The Hospitalist Company, Inc. CENTRAL INDEX KEY: 0001410471 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MISC HEALTH & ALLIED SERVICES, NEC [8090] IRS NUMBER: 954562058 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 4605 LANKERSHIM BLVD., SUITE 617 CITY: NORTH HOLLYWOOD STATE: CA ZIP: 91602 BUSINESS PHONE: 818-766-3502 MAIL ADDRESS: STREET 1: 4605 LANKERSHIM BLVD., SUITE 617 CITY: NORTH HOLLYWOOD STATE: CA ZIP: 91602 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Singer Adam D MD CENTRAL INDEX KEY: 0001424032 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-33930 FILM NUMBER: 131019505 MAIL ADDRESS: STREET 1: C/O IPC THE HOSPITALIST COMPANY, INC. STREET 2: 4605 LANKERSHIM BLVD SUITE 617 CITY: NORTH HOLLYWOOD STATE: CA ZIP: 91602 4 1 rrd387785.xml FORM 4 - ADAM SINGER 8.6.2013 X0306 4 2013-08-06 0 0001410471 IPC The Hospitalist Company, Inc. IPCM 0001424032 Singer Adam D MD C/O IPC THE HOSPITALIST COMPANY, INC. 4605 LANKERSHIM BLVD., STE 617 NORTH HOLLYWOOD CA 91602 1 1 0 0 CEO & Chairman Common Stock 2013-08-06 4 M 0 6500 17.54 A 77975 D Common Stock 2013-08-06 4 S 0 6500 50.8026 D 71475 D Common Stock 25006 I Emerald Isle Trust Common Stock 25006 I Whitehall Trust Stock Option (Right-to-Buy) 17.54 2013-08-06 4 M 0 6500 0 D 2018-03-19 Common Stock 6500 27096 D Amount includes 62,500 shares held by IPC Living Trust of which Adam D. Singer, M.D. is the sole beneficiary and sole trustee and 8,975 shares of Common Stock subject to unvested Restricted Stock Grant. Shares held by Emerald Isle Trust of which Adam D. Singer, M.D. is trustee. Shares held by Whitehall Trust of which Adam D. Singer, M.D. is trustee. The option execise and sale reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 17, 2012. Options were granted on March 19, 2008. 25% of the options vest twelve months after the anniversary of the grant date. The remainder will vest in equal amounts monthly over the subsequent 36 months. /s/ Fernando Sarria, attorney-in-fact 2013-08-07